Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Skin Neoplasms 1Prostatic Neoplasms 1Melanoma 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × pimonidazole × Clear all
NCT01992042 2017-10-26

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
33 enrolled
Genitourinary

Prostatic Neoplasms

NCT02414048 2016-06-17

Hypoxia Analysis in Head and/or Neck Cancer

University of Zurich

Phase 2 Unknown
10 enrolled
Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT02061007 2016-05-09

Biomarker Correlates of Hypoxia in Metastatic Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡